These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Extended-release formulations in epilepsy. Verrotti A; Salladini C; Di Marco G; Pisciella F; Chiarelli F J Child Neurol; 2007 Apr; 22(4):419-26. PubMed ID: 17621521 [TBL] [Abstract][Full Text] [Related]
8. Inverse correlation of valproic acid serum concentrations and quality of life in adolescents with epilepsy. Jakovljevic MB; Jankovic SM; Jankovic SV; Todorovic N Epilepsy Res; 2008 Aug; 80(2-3):180-3. PubMed ID: 18495431 [TBL] [Abstract][Full Text] [Related]
9. [Depakine in the therapy of epilepsy in children and adolescents]. Guzeva VI; Fomina MIu; Korostovtsev DD; Guzeva VV; Guzeva OV Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(8):34-9. PubMed ID: 18379470 [TBL] [Abstract][Full Text] [Related]
10. [Therapeutic Drug Monitoring of Valproic Acid in Children: A Prospective Study of The Effect of The Compliance and The Economic Level on the Trough Plasmatic Concentrations and Epileptic Seizures]. Charfi R; Lakhal M; Klouz A; Trabelsi S; Salouage I Therapie; 2015; 70(5):415-24. PubMed ID: 26071142 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children. Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762 [TBL] [Abstract][Full Text] [Related]
12. A comparative evaluation of pharmacokinetics of conventional and slow-release carbamazepine formulation in newly treated patients of epilepsy: a random evaluation. Nag D; Garg RK; Agarwal A J Assoc Physicians India; 1998 Feb; 46(2):185-8. PubMed ID: 11273108 [TBL] [Abstract][Full Text] [Related]
13. [Depakine: 25 years in Russia]. Karlov VA Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):129-134. PubMed ID: 29265098 [TBL] [Abstract][Full Text] [Related]
14. New generation of valproic acid. Trojnar MK; Wierzchowska-Cioch E; Krzyzanowski M; Jargiełło M; Czuczwar SJ Pol J Pharmacol; 2004; 56(3):283-8. PubMed ID: 15215557 [TBL] [Abstract][Full Text] [Related]
15. Does it really matter when a blood sample for valproic acid concentration is taken following once-daily administration of divalproex-ER? Reed RC; Dutta S Ther Drug Monit; 2006 Jun; 28(3):413-8. PubMed ID: 16778728 [TBL] [Abstract][Full Text] [Related]
16. [Depakene (sodium valproate) in the treatment of epilepsy in children and adolescents: efficiency and safety]. Petrukhin AS; Mukhin KIu Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(6):20-7. PubMed ID: 11517881 [TBL] [Abstract][Full Text] [Related]
17. Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy. Galimberti CA; Mazzucchelli I; Arbasino C; Canevini MP; Fattore C; Perucca E Epilepsia; 2006 Sep; 47(9):1569-72. PubMed ID: 16981874 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring of antiepileptic drugs. Shakya G; Malla S; Shakya KN; Shrestha R JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370 [TBL] [Abstract][Full Text] [Related]
19. Epileptic seizures caused by low valproic acid levels from an interaction with meropenem. Fudio S; Carcas A; Piñana E; Ortega R J Clin Pharm Ther; 2006 Aug; 31(4):393-6. PubMed ID: 16882111 [TBL] [Abstract][Full Text] [Related]
20. Effect of concomitant administration of meropenem and valproic acid in an elderly Chinese patient. Gu J; Huang Y Am J Geriatr Pharmacother; 2009 Feb; 7(1):26-33. PubMed ID: 19281938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]